RVEc

BIOLOGICAL3 trials

Sponsors

U.S. Army Medical Research and Development Command

Conditions

RicinRicin Poisoning

Phase 1

Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™)

CompletedNCT01317667

U.S. Army Medical Research and Development CommandRicin

Start: 2011-03-31End: 2014-12-31Updated: 2020-01-03

IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost

WithdrawnNCT02385825

U.S. Army Medical Research and Development CommandRicin Poisoning

Start: 2016-04-30End: 2017-12-31Updated: 2020-01-02

ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With Boost

WithdrawnNCT02386150

U.S. Army Medical Research and Development CommandRicin Poisoning

Start: 2017-10-31End: 2018-12-31Updated: 2020-01-02

Related Papers

Safety and immunogenicity of ricin vaccine, RVEc™, in a Phase 1 clinical trial.

2015-11-0323 citations